You are here: Industry Insights > FDA

News List

Drug Marketing in China and Worldwide (June) Caicai/PharmaSources
July 12, 2023
Drug Marketing in China and Worldwide (June)
Drug Marketing in China and Worldwide (May) Caicai/PharmaSources
July 12, 2023
Drug Marketing in China and Worldwide (May)
Astellas’ non-hormonal VMS therapy gets FDA approval SHEM OIRERE
June 08, 2023
U.S. Food and Drug Administration has approved Veozah, the first neurokinin 3 receptor antagonist, to treat moderate to severe vasomotor symptoms.
Innovative Drug HER2 ADC Rejected for Marketing, Stricter FDA Review May be Normal in the Future Xiaobin/PharmaSources
June 06, 2023
The FDA's rejection of the marketing of SYD985 is just the beginning, and with the rising enthusiasm for the R&D of ADCs, the standards of subsequent review by the FDA of the popular target ADCs will be inevitably raised.
FDA's Approval was Postponed Again, Chinese Innovative Pharmaceutical Companies has Extended Their Businesses to the Middle East and North Africa PharmaSources
April 27, 2023
The export of domestic PD-1 is much more difficult than expected.The Middle East and North Africa has become a new choice for the export of domestic innovative pharmaceutical companies in the past two years.
Pharma packaging regulations of NMPA, EMA and FDA Muhammad Asim Niazi
March 21, 2023
There are various regulatory bodies globally that take part in constituting packaging regulations. The pharma manufacturer is requires to comply with the regulations of body, in which it intends to produce or market its manufactured drug.
Why Drug regulatory authority updates their Rules and Regulations Muhammad Asim Niazi
March 21, 2023
Pharmaceutical regulatory authorities regularly update their rules and regulations regarding drug review and approval.
Pharma Co-packaging Regulations Muhammad Asim Niazi
March 21, 2023
Let’s discuss some regulatory requirements for contract packaging in line with three most competitive markets i.e China , United States and Europe.
Drug Marketing in China and Worldwide (July) Caicai/PharmaSources
August 11, 2023
On July 6th, Eisai's lecanemab (Leqembi) was fully approved by the FDA for the treatment of Alzheimer's disease
3D Printing: A Perfect Storm for Pharma Industry and Regulatory Agency PharmaSources/Eric Sun, Ph.D.
April 12, 2022
3D printing or additive manufacturing is a process of creating three-dimensional solid objects from a digital design. The process involves printing sequentially thin layers of the building materials until the object is created.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 365 366 Next page